Inhibition of eukaryotic initiation factor 4E by tomivosertib suppresses angiogenesis, growth and survival of glioblastoma and enhances chemotherapy’s efficacy
Inhibition of eukaryotic initiation factor 4E by tomivosertib suppresses angiogenesis, growth and survival of glioblastoma and enhances chemotherapy’s efficacy
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started